Developing a Quantitative Assessment Tool for Characterizing Social Domains

开发用于表征社会领域的定量评估工具

基本信息

  • 批准号:
    10586621
  • 负责人:
  • 金额:
    $ 56.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-07 至 2027-07-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract Social deficits occur across a wide array of neuropsychiatric (NPD) and neurodevelopmental (NDD) disorders and contribute to poor outcomes and sizable public health costs. However, the lack of adequate characterization of mechanisms underpinning social impairments by the current categorical diagnostic systems has significantly stifled the development of etiologically based, individually tailored treatments. A fully dimensional alternative to the categorical frameworks offered by the National Institute of Mental Health’s Research Domain Criteria (RDoC) holds particular promise for a better understanding of mechanisms behind social deficits. More specifically, the RDoC initiative operationalizes an initial set of basic, biologically meaningful components that underpin social functioning, and if disrupted, can impede one’s ability to navigate the complexities of the social world. These processes can therefore be used to better understand social deficits seen across NPD/NDD and inform personalization of treatments. However, we currently lack dedicated measures able to comprehensively capture components of social functioning across clinical, at risk and normative populations which has significantly impeded the translation and adoption of this potentially promising framework. Therefore, the overarching aim of this project is to further expand a recently developed RDoC-based social processes scale: The Stanford Social Dimensions Scale (SSDS). The goal is to refine, factorize, validate and establish regression-based norms of the updated SSDS (SSDS-2). We will also aim to construct a preliminary computerized adaptive testing (CAT) version of the SSDS-2 that will enable individually tailored item selection and administration. These objectives will be achieved by: 1) obtaining feedback on a preliminary item bank from experts and parents of children from normative and clinical groups in order to evaluate the content validity, developmental appropriateness and clinical relevance of the items and to guide the item refinement (Specific Aim 1); 2) utilizing advanced psychometric approaches including exploratory structural equation modeling and item response theory on a large online recruited clinically diverse and normative sample to establish the factor structure (Specific Aim 2); 3) confirming factor structure of the SSDS-2, establishing regression based and standardized change norms and constructing a preliminary CAT version (Specific Aim 3); and further validating the SSDS-2 through an in-person multi-method assessment protocol encompassing interview, observational and experimental methodology with a transdiagnostic sample of youth with a range of social abilities and typically developing youth and their parents. An additional goal is to examine the association between the SSDS-2 subdomains with the neural networks subserving corresponding social processes in a transdiagnostic subsample of youth (Specific Aim 4). This project will lay the foundation for future investigations aimed at: (i) extending the new measure to different age groups (2-5 years and adulthood); (ii) developing a companion clinician-rated structured interview, and (iii) testing its utility as a clinical outcome measure.
项目摘要/摘要 社会缺陷发生在各种神经精神病学(NPD)和神经发育(NDD)疾病中 并促进不良结果和相当大的公共卫生费用。但是,缺乏足够的 通过当前的分类诊断系统的社会障碍的机制表征 已经显着维护了基于病因的,单独量身定制的治疗的发展。一个 国家心理健康研究所提供的分类框架的维度替代方案 研究领域标准(RDOC)具有特别的希望,以更好地理解背后的机制 社会缺陷。更具体地说,RDOC初始运行一组基本,生物学上有意义的一组 支撑社会功能且如果受到干扰的组成部分可能会阻碍人们导航的能力 社会世界的复杂性。因此,这些过程可用于更好地了解社会缺陷 请参阅NPD/NDD,并告知治疗的个性化。但是,我们目前缺乏专用 措施可以全面捕获整个临床,有风险和 正常人口极大地阻碍了这种潜在诺言的翻译和采用 框架。因此,该项目的总体目的是进一步扩展最近开发的基于RDOC 社会过程规模:斯坦福大学社会维度量表(SSD)。目标是完善,分解,验证 并建立更新的SSD(SSDS-2)的基于回归的规范。我们还将旨在构建 SSDS-2的初步计算机化自适应测试(CAT)版本将启用单独量身定制的项目 选择和管理。这些目标将通过:1)获得初步项目的反馈 来自正常和临床组的专家和父母的银行,以评估内容 项目的有效性,发育适当性和临床相关性,并指导项目的完善 (特定目标1); 2)使用高级心理测量方法,包括探索性结构方程 大型在线招募临床多样化和正常样本的建模和项目响应理论 建立因子结构(特定目标2); 3)确认SSD-2的因素结构,建立 基于回归和标准化的变更规范并构建初步的CAT版本(特定AIM 3); 并通过面对面的多方法评估协议进一步验证SSDS-2 访谈,观察和实验方法学,与一系列范围的经诊断样本 社会能力,通常发展青年及其父母。另一个目标是检查协会 在SSDS-2子域之间与神经网络之间的联系 青年的转诊子样本(特定目标4)。该项目将为未来的调查奠定基础 针对:(i)将新的测量值扩展到不同年龄段(2-5岁和成年); (ii)开发 伴侣临床评级的结构化访谈,以及(iii)测试其效用作为临床结果度量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

ANTONIO HARDAN的其他基金

Project 2: Pharmacological Probing of Sleep Physiology in Autism
项目2:自闭症睡眠生理学的药理学探索
  • 批准号:
    10698075
    10698075
  • 财政年份:
    2022
  • 资助金额:
    $ 56.64万
    $ 56.64万
  • 项目类别:
Project 2: Pharmacological Probing of Sleep Physiology in Autism
项目2:自闭症睡眠生理学的药理学探索
  • 批准号:
    10531475
    10531475
  • 财政年份:
    2022
  • 资助金额:
    $ 56.64万
    $ 56.64万
  • 项目类别:
A Big Data Approach Toward the Development of a New Quantitative Measure of Restricted and Repetitive Behaviors
利用大数据方法开发限制性和重复性行为的新量化指标
  • 批准号:
    10066368
    10066368
  • 财政年份:
    2019
  • 资助金额:
    $ 56.64万
    $ 56.64万
  • 项目类别:
Identification of RDoC Social Communication Sub-Constructs Using Existing Datasets
使用现有数据集识别 RDoC 社交沟通子结构
  • 批准号:
    9224382
    9224382
  • 财政年份:
    2017
  • 资助金额:
    $ 56.64万
    $ 56.64万
  • 项目类别:
Intranasal vasopressin treatment in children with autism
自闭症儿童鼻内加压素治疗
  • 批准号:
    9893009
    9893009
  • 财政年份:
    2017
  • 资助金额:
    $ 56.64万
    $ 56.64万
  • 项目类别:
Quantitative Measurements of Cortical Excitability in Neurodevelopmental Disorder
神经发育障碍中皮质兴奋性的定量测量
  • 批准号:
    9110300
    9110300
  • 财政年份:
    2015
  • 资助金额:
    $ 56.64万
    $ 56.64万
  • 项目类别:
Pivotal Response Treatment Package for Young Children with Autism
自闭症幼儿关键应对治疗方案
  • 批准号:
    8623747
    8623747
  • 财政年份:
    2014
  • 资助金额:
    $ 56.64万
    $ 56.64万
  • 项目类别:
The role of vasopressin in the social deficits of autism
加压素在自闭症社交缺陷中的作用
  • 批准号:
    8491054
    8491054
  • 财政年份:
    2013
  • 资助金额:
    $ 56.64万
    $ 56.64万
  • 项目类别:
The role of vasopressin in the social deficits of autism
加压素在自闭症社交缺陷中的作用
  • 批准号:
    8706972
    8706972
  • 财政年份:
    2013
  • 资助金额:
    $ 56.64万
    $ 56.64万
  • 项目类别:
A neuroimaging study of twin pairs with autism
自闭症双胞胎的神经影像学研究
  • 批准号:
    8205000
    8205000
  • 财政年份:
    2009
  • 资助金额:
    $ 56.64万
    $ 56.64万
  • 项目类别:

相似国自然基金

签字注册会计师动态配置问题研究:基于临阵换师视角
  • 批准号:
    72362023
  • 批准年份:
    2023
  • 资助金额:
    28 万元
  • 项目类别:
    地区科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
  • 批准号:
    72372064
  • 批准年份:
    2023
  • 资助金额:
    40 万元
  • 项目类别:
    面上项目
会计师事务所数字化能力构建:动机、经济后果及作用机制
  • 批准号:
    72372028
  • 批准年份:
    2023
  • 资助金额:
    42.00 万元
  • 项目类别:
    面上项目
会计师事务所薪酬激励机制:理论框架、激励效应检验与优化重构
  • 批准号:
    72362001
  • 批准年份:
    2023
  • 资助金额:
    28.00 万元
  • 项目类别:
    地区科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
  • 批准号:
    72332002
  • 批准年份:
    2023
  • 资助金额:
    165.00 万元
  • 项目类别:
    重点项目

相似海外基金

A closed-loop gravity infusion control device
一种闭环重力输液控制装置
  • 批准号:
    10384629
    10384629
  • 财政年份:
    2022
  • 资助金额:
    $ 56.64万
    $ 56.64万
  • 项目类别:
Clearbot: a system for fully automated, high-throughput tissue clearing and immunostaining
Clearbot:全自动、高通量组织透明化和免疫染色系统
  • 批准号:
    10382515
    10382515
  • 财政年份:
    2022
  • 资助金额:
    $ 56.64万
    $ 56.64万
  • 项目类别:
Magnetic Bronchoscope for Improved Pulmonary Access
用于改善肺部通路的磁力支气管镜
  • 批准号:
    10152980
    10152980
  • 财政年份:
    2021
  • 资助金额:
    $ 56.64万
    $ 56.64万
  • 项目类别:
Automated three-dimensional spinal navigation system for chronic pain therapy
用于慢性疼痛治疗的自动化三维脊柱导航系统
  • 批准号:
    10384241
    10384241
  • 财政年份:
    2021
  • 资助金额:
    $ 56.64万
    $ 56.64万
  • 项目类别:
Automated three-dimensional spinal navigation system for chronic pain therapy
用于慢性疼痛治疗的自动化三维脊柱导航系统
  • 批准号:
    10490879
    10490879
  • 财政年份:
    2021
  • 资助金额:
    $ 56.64万
    $ 56.64万
  • 项目类别: